By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CMC Biologics 

22021 20th Avenue SE

Bothell  Washington  98021  U.S.A.
Phone: 425-485-1900 Fax: 425-486-0300


CMC Biologics is a global contract process development and manufacturer of biopharmaceuticals. We offer our clients a full suite of contract services from DNA to API and leverage our technical expertise to transform these services into solutions that meet our clients’ near- and long-term objectives. With cGMP compliant facilities in both the United States and Europe and a team of more than 500 dedicated employees, every project is performed with our absolute commitment to quality manufacturing and customer satisfaction.

While our efforts touch a defined part of the expansive drug development and commercialization continuum, we see ourselves as partners in our clients’ success bringing products to patients. CMC Biologics has become our clients’ manufacturing partner of choice because they trust us to make their needs and objectives our own.

Key Statistics

Ownership: Private

Web Site: CMC Biologics


Company News
Through Their PROVEO Partnership, CMC Biologics And IDT Biologika Announce The Addition Of Cerbios-Pharma And Oncotec Pharma To Their Strategic Collaboration For Manufacture Of Antibody Drug Conjugates 10/13/2016 7:33:24 AM
CMC Biologics Cleared For Commercial Manufacture Of CSL Behring's FDA-Approved AFSTYLA 6/15/2016 11:08:02 AM
f-Star Announces An Agreement With CMC Biologics For Manufacture Of mAb2 Bispecific Antibodies 6/7/2016 2:40:58 PM
CMC Biologics Expands GMP Manufacturing Capacity In Europe 6/2/2016 7:29:31 AM
CMC Biologics Recognized As A Leader In Contract Development And Manufacturing By Customers And The Biopharmaceutical Industry 3/29/2016 9:08:33 AM
CMC Biologics And IDT Biologika Announce A Strategic Collaboration To Manufacture Antibody Drug Conjugates 2/17/2016 11:18:59 AM
CMC Biologics Announces Appointment Of New CEO 10/20/2015 10:08:03 AM
Governor Inslee's Director Of Life Science And Global Health Development, Maura Little, Presides Over CMC Biologics' Ribbon Cutting Ceremony Commemorating The Bioreactor 6 Pack Manufacturing Facility 10/7/2015 9:44:42 AM
CMC Biologics Enters Into Agreement With The PATH Malaria Vaccine Initiative For Accelerated Development And Manufacturing Of Monoclonal Antibodies 8/12/2015 9:06:59 AM
CMC Biologics And River Vision Development Corporation Announce Manufacturing Agreement For RV001, A Monoclonal Antibody To Treat Grave's Orbitopathy 7/29/2015 12:57:03 PM